Comparative effectiveness of novel oral anticoagulants in UK patients with non-valvular atrial fibrillation and chronic kidney disease: a matched cohort study
Objectives To evaluate the effectiveness and safety of novel oral anticoagulants (NOACs) compared with vitamin K antagonists (VKAs) among patients with non-valvular atrial fibrillation (NVAF), particularly those with chronic kidney disease (CKD).Design Population-based matched cohort study.Setting O...
Saved in:
| Main Authors: | Samy Suissa, James M Brophy, Sophie Dell’Aniello, Christel Renoux, Simone Y Loo, Janie Coulombe |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2018-01-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/8/1/e019638.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Risk of Severe Exacerbation Associated with Gabapentinoid Use in Patients with Chronic Obstructive Pulmonary Disease: A Population-Based Cohort Study
by: Omotayo Olaoye, et al.
Published: (2025-12-01) -
Triple Inhaler versus Dual Bronchodilator Therapy in COPD: Real-World Effectiveness on Mortality
by: Samy Suissa, et al.
Published: (2022-12-01) -
Anticoagulation in Atrial Fibrillation With Valvular Heart Disease
by: Ana Catarina Fonseca, et al.
Published: (2025-02-01) -
Effectiveness of Aspirin on Major COPD Outcomes: A Prevalent New-User Design Observational Study
by: Charles Khouri, et al.
Published: (2024-12-01) -
Cost-effectiveness of direct oral anticoagulants in non-valvular atrial fibrillation
by: Inigo Gorostiza, et al.
Published: (2025-01-01)